missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human DSCR3 (aa 82-155) Control Fragment Recombinant Protein
Description
Highest antigen sequence indentity to the following orthologs: Mouse (91%), Rat (91%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-54747 (PA5-54747. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
The region of chromosome 21 between genes CBR and ERG (CBR-ERG region), which spans 2.5 Mb on 21q22.2, has been defined by analysis of patients with partial trisomy 21. It contributes significantly to the pathogenesis of many characteristics of Down syndrome, including morphological features, hypotonia, and mental retardation. The DSCR3 (Down syndrome critical region gene 3) gene is found in this region and is predictated to contain eight exons. DSCR3 is expressed in most tissues examined.
Specifications
Specifications
| Accession Number | O14972 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 10311 |
| Name | Human DSCR3 (aa 82-155) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | DCRA; Down syndrome critical region 3; Down syndrome critical region gene 3; Down syndrome critical region protein 3; Down syndrome critical region protein A; DSCR3; DSCR3 arrestin fold containing; DSCRA; Vacuolar protein sorting-associated protein 26 C; VPS26C |
| Common Name | DSCR3 |
| Show More |